2 completed, 2 unknown. 2 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Unknown 2 |
| Phase 3 | 2 | Completed 2 |
Follow Bismuth-containing quadruple therapy: new trials by email Literature Review of Bismuth-containing quadruple therapy trials Research Report on Bismuth-containing quadruple therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection clarithromycin-sensitive(first-line), clarithromycin-resistant(first-line), empirical therapy group first-line - Helicobacter Pylori Infection | Not applicable | Unknown | Liaocheng People's Hospital | 500 | 2022-09-20 | 2023-12-12 |
| Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection JWC containing quadruple therapy, Bismuth-containing quadruple therapy - Helicobacter Pylori Infection | Not applicable | Unknown | Peking University First Hospital | 80 | 2022-06-20 | 2022-10-18 |
| Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection TAK-438, Lansoprazole, TAK-438 Placebo - Gastric Ulcer | Phase 3 | Completed | Takeda | 234 | 2017-04-17 | 2021-06-18 |
| Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection TAK-438, Lansoprazole, TAK-438 Placebo - Duodenal Ulcer | Phase 3 | Completed | Takeda | 533 | 2017-04-05 | 2020-06-12 |
Digestive System Diseases (1) · Duodenal Ulcer (1) · Gastrointestinal Diseases (1) · Glomerulonephritis, IGA (1) · Stomach Ulcer (1)
Takeda (2) · Liaocheng People's Hospital (1) · Peking University First Hospital (1)
China (4) · Philippines (2) · South Korea (2) · Taiwan (2)